Alan D Mendelsohn, MD in Hollywood, FL - Medicare Ophthalmology

Alan D Mendelsohn, MD is a medicare enrolled "Ophthalmology" physician in Hollywood, Florida. He went to Northwestern University Feinberg Medical School and graduated in 1982 and has 42 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Eye Surgeon And Consultants Pa and his current practice location is 4651 Sheridan St, Suite 100, Hollywood, Florida. You can reach out to his office (for appointments etc.) via phone at (954) 894-1500.

Alan D Mendelsohn is licensed to practice in Florida (license number ME0047764) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1053308460.

Contact Information

	Alan D Mendelsohn, MD
	4651 Sheridan St, Suite 100, Hollywood, FL 33021-3457
	(954) 894-1500
	(954) 894-1526

Physician's Profile

Full Name	Alan D Mendelsohn
Gender	Male
Speciality	Ophthalmology
Experience	42 Years
Location	4651 Sheridan St, Hollywood, Florida
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Alan D Mendelsohn attended and graduated from Northwestern University Feinberg Medical School in 1982

NPI Data:

NPI Number: 1053308460
Provider Enumeration Date: 09/30/2005
Last Update Date: 01/07/2011

Medicare PECOS Information:

PECOS PAC ID: 6002816055
Enrollment ID: I20061222000151

Medical Identifiers

Medical identifiers for Alan D Mendelsohn such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053308460	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	ME0047764 (Florida)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Eye Surgeon And Consultants Pa	6507866449	2

News Archive

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

A novel class of cancer therapies called live biologics is offering new hope for patients affected by hard-to-treat cancers, according to two different studies testing the therapies in patients with sarcomas and head and neck cancers.

New FDA committee to address risk communication

The U.S. Food and Drug Administration (FDA) today announced a new advisory committee designed to counsel the agency on how to strengthen the communication of risks and benefits of FDA-regulated products to the public.

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

As world leaders meet this week to review progress and chart the future course of the global AIDS response at the 2011 UN General Assembly High-Level Meeting on AIDS in New York, the International AIDS Society (IAS) calls on leaders to ensure the inclusion of HIV cure research and its global strategy into the international HIV agenda and in all discussions, political decisions and funding strategies.

We unconsciously make use of recent experiences during estimation processes

During estimation processes we unconsciously make use of recent experiences. Scientists from Ludwig-Maximilians-Universit-t (LMU) in Munich and the Bernstein Center Munich asked test subjects to estimate distances in a virtual reality environment.

Children's characteristics may determine response to inhaled corticosteroid therapy for asthma

In a study published online in the Journal of Allergy and Clinical Immunology, researchers at Washington University School of Medicine in St. Louis and five other sites nationwide found that children who showed the most improvement in days without wheezing using an inhaled corticosteroid drug were caucasian boys who had allergies and had a hospitalization or emergency department visit for asthma symptoms in the year prior to the trial.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Alan D Mendelsohn allows following entities to bill medicare on his behalf.

Entity Name	Eye Surgeon & Consultants Pa
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1649376914 PECOS PAC ID: 6507866449 Enrollment ID: O20061228000128

News Archive

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

New FDA committee to address risk communication

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

We unconsciously make use of recent experiences during estimation processes

Children's characteristics may determine response to inhaled corticosteroid therapy for asthma

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alan D Mendelsohn is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Alan D Mendelsohn, MD 4651 Sheridan St, Suite 100, Hollywood, FL 33021-3457 Ph: (954) 894-1500	Alan D Mendelsohn, MD 4651 Sheridan St, Suite 100, Hollywood, FL 33021-3457 Ph: (954) 894-1500

News Archive

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

New FDA committee to address risk communication

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

We unconsciously make use of recent experiences during estimation processes

Children's characteristics may determine response to inhaled corticosteroid therapy for asthma

Ophthalmology Doctors in Hollywood, FL

Scott C Cardone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 300 S Park Rd Ste 300, Hollywood, FL 33021 Phone: 954-925-2740 Fax: 954-923-8379
Mr. Joel Sandberg, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 300 S Park Rd Ste 300, Hollywood, FL 33021 Phone: 954-925-2740 Fax: 954-923-8379
Dr. Michael Glassman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 300 S Park Rd Ste 300, Hollywood, FL 33021 Phone: 954-925-2740 Fax: 954-923-8379
Mr. Guy Angella, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 300 S Park Rd Ste 300, Hollywood, FL 33021 Phone: 954-925-2740 Fax: 954-923-8379
Michael Kanner, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4651 Sheridan St Ste 100, Hollywood, FL 33021 Phone: 954-894-1500 Fax: 954-894-1526
Albert Gasper Caruana Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 300 S Park Rd Ste 300, Hollywood, FL 33021 Phone: 954-925-2740 Fax: 954-923-8379

Alan D Mendelsohn, MD - Medicare Ophthalmology in Hollywood, FL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

New FDA committee to address risk communication

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

We unconsciously make use of recent experiences during estimation processes

Children's characteristics may determine response to inhaled corticosteroid therapy for asthma

Medicare Reassignments

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

New FDA committee to address risk communication

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

We unconsciously make use of recent experiences during estimation processes

Children's characteristics may determine response to inhaled corticosteroid therapy for asthma

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

New FDA committee to address risk communication

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

We unconsciously make use of recent experiences during estimation processes

Children's characteristics may determine response to inhaled corticosteroid therapy for asthma

Ophthalmology Doctors in Hollywood, FL